Find a Clinical Trial
Filter
AEROVATE Extension
Interstitial lung diseases, Pulmonary hypertension
All genders
18-75
Recruiting now
Department of Medicine, Division of Pulmonary, Critical Care + Sleep Medicine
Collagen Urine Assay
Male
50-80
Recruiting now
Department of Urology
CADENCE Study
Heart failure, Pulmonary hypertension
All genders
18-85
Recruiting now
Department of Medicine, Division of Pulmonary, Critical Care + Sleep Medicine
A Phase 2, Open-Label, Dose Escalation Study to Evaluate the Safety and Efficacy of RT234
Pulmonary hypertension
All genders
18-80
Recruiting now
Department of Medicine, Division of Pulmonary, Critical Care + Sleep Medicine
Insmed TPIP Study
Interstitial lung diseases, Pulmonary hypertension
All genders
18-75
Recruiting now
Department of Medicine, Division of Pulmonary, Critical Care + Sleep Medicine
Tenax Phase 3: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
All genders
18+
Recruiting now
Department of Medicine, Division of Pulmonary, Critical Care + Sleep Medicine
A Phase 3 Study of Sotatercept for the Treatment of PAH
Pulmonary hypertension
All genders
18-18
Recruiting now
Department of Medicine, Division of Pulmonary, Critical Care + Sleep Medicine
A Phase 3 Study of Sotatercept in Newly Diagnosed Intermediate- and High-risk PAH Patients
Pulmonary hypertension
All genders
18+
Recruiting now
Department of Medicine, Division of Pulmonary, Critical Care + Sleep Medicine
A Phase 3 Study of Sotatercept in Participants with PAH WHO FC III or FC IV at High Risk of Mortality
Pulmonary hypertension
All genders
18-75
Recruiting now
Department of Medicine, Division of Pulmonary, Critical Care + Sleep Medicine
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center